|
|
|
|
LEADER |
00000nam a22000005i 4500 |
001 |
b3234911 |
003 |
MWH |
005 |
20190619193300.0 |
007 |
cr nn 008mamaa |
008 |
130622s1997 xxu| s |||| 0|eng d |
020 |
|
|
|a 9781475766325
|
024 |
7 |
|
|a 10.1007/978-1-4757-6632-5
|2 doi
|
035 |
|
|
|a (DE-He213)978-1-4757-6632-5
|
050 |
|
4 |
|a E-Book
|
072 |
|
7 |
|a MJR
|2 bicssc
|
072 |
|
7 |
|a MED055000
|2 bisacsh
|
072 |
|
7 |
|a MJR
|2 thema
|
245 |
1 |
0 |
|a Suki and Massry’s Therapy of Renal Diseases and Related Disorders
|h [electronic resource] /
|c edited by Wadi N. Suki, Shaul G. Massry.
|
250 |
|
|
|a 3rd ed. 1997.
|
264 |
|
1 |
|a New York, NY :
|b Springer US :
|b Imprint: Springer,
|c 1997.
|
300 |
|
|
|a L, 1273 p. 65 illus.
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a text file
|b PDF
|2 rda
|
490 |
1 |
|
|a Springer eBook Collection
|
505 |
0 |
|
|a One: Disorders of Fluid, Electrolyte, and Acid-Base Balance -- 1. Pathogenesis and treatment of hypoosmolar and hyperosmolar states -- 2. Polyuric syndromes -- 3. Edematous states -- 4. Disorders of potassium metabolism -- 5. Disorders of calcium metabolism -- 6. Disorders of magnesium homeostasis and magnesium in therapy -- 7. Disorders of phosphate metabolism -- 8. Nephrolithiasis and nephrocalcinosis -- 9. Metabolic alkalosis: biochemical mechanisms, pathophysiology, and treatment -- 10. Therapy of lactic acidosis -- 11. Diabetic ketoacidosis and hyperosmolar nonketotic syndrome -- 12. Metabolic acidosis -- 13. Renal tubular acidosis -- 14. Respiratory acid-base disorders -- 15. Mixed acid-base disorders -- 16. Fluid and electrolyte abnormalities in children -- 17. Fluid and electrolyte disorders in the surgical patient -- 18. Fluid and electrolyte disorders in the thermally injured -- 19. Acute renal failure -- Two: Intrinsic Parenchymal Disease -- 20. Acute glomerulonephritis -- 21. Glomerulonephritis in bacterial endocarditis -- 22. Goodpasture’s syndrome -- 23. Nephrotic syndrome -- 24. Hematuria and IgA nephropathy -- 25. Infections of the urinary tract -- 26. Vesicoureteral reflux and reflux nephropathy -- 27. Genitourinary tuberculosis -- Three: Renal Involvement in Systemic Disease -- 28. Systemic lupus erythematosus -- 29. Vasculitic diseases of the kidney -- 30. Noninflammatory vascular disease of the kidney -- 31. Thrombotic microangiopathy -- 32. Multiple myeloma and plasma cell dyscrasias -- 33. Hyperuricemic nephropathy -- 34. The effects of jaundice and cholemia on kidney function and the cardiovascular system -- 35. Renal complications of pregnancy -- 36. Prevention and early treatment of diabetic renal disease -- 37. Renal complications of intravenous drug abuse and human immunodeficiency virus infection -- Four: Hereditary and Congenital Diseases -- 38. Renal cystic disease -- 39. Therapy of the renal complications of sickle cell hemoglobinopathy -- 40. Inherited renal tubular disorders -- 41. Genetic diagnosis and counseling in inherited renal diseases -- Five: Neoplasia -- 42. Cancers of the urinary tract -- Six: Chemical and Physical Injuries -- 43. Toxic nephropathy -- 44. Acute drug intoxications -- Seven: Chronic Renal Failure -- 45. Prevention of progression of renal disease -- 46. Renal insufficiency -- 47. Anesthesia and surgery in the patient with renal failure -- 48. Nutritional management of the uremic patient -- 49. Treatment of hyperlipidemia in the nephrotic syndrome -- 50. Cardiovascular complications in uremia and dialysis -- 51. Renal osteodystrophy: prevention and management -- 52. Neurologic and psychiatric disorders in renal diseases -- 53. Hematologic disorders in renal failure -- 54. Hepatitis in the renal patient -- 55. Acute, intermittent, and cycled peritoneal dialysis -- 56. Continuous ambulatory peritoneal dialysis -- 57. Peritoneal catheter placement and management -- 58. Peritonitis and other complications -- 59. Dialysis access: temporary and permanent -- 60. Dialyzers, dialysates, and water treatment -- 61. Membrane biocompatibility -- 62. Hemodialysis, ultrafiltration, and hemofiltration -- 63. Use of drugs in uremia and dialysis -- 64. Donor and recipient selection -- 65. Immunosuppression and treatment of rejection -- 66. Tubular and metabolic dysfunction following transplantation -- 67. Transplantation in inherited systemic and metabolic diseases -- 68. Complications of renal transplantation -- Eight: Hypertension -- 69. Essential hypertension -- 70. Renal and renovascular hypertension -- 71. Posttransplant hypertension -- Nine: Urologic Disorders -- 72. The catheter -- 73. Nonsurgical management of vesicourethral dysfunction.
|
590 |
|
|
|a Loaded electronically.
|
590 |
|
|
|a Electronic access restricted to members of the Holy Cross Community.
|
650 |
|
0 |
|a Nephrology.
|
650 |
|
0 |
|a Medicine.
|
650 |
|
0 |
|a Internal medicine.
|
690 |
|
|
|a Electronic resources (E-books)
|
700 |
1 |
|
|a Suki, Wadi N.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
700 |
1 |
|
|a Massry, Shaul G.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|
830 |
|
0 |
|a Springer eBook Collection.
|
856 |
4 |
0 |
|u https://holycross.idm.oclc.org/login?auth=cas&url=https://doi.org/10.1007/978-1-4757-6632-5
|3 Click to view e-book
|t 0
|
907 |
|
|
|a .b32349117
|b 04-18-22
|c 02-26-20
|
998 |
|
|
|a he
|b 02-26-20
|c m
|d @
|e -
|f eng
|g xxu
|h 0
|i 1
|
912 |
|
|
|a ZDB-2-SME
|
912 |
|
|
|a ZDB-2-BAE
|
950 |
|
|
|a Medicine (Springer-11650)
|
902 |
|
|
|a springer purchased ebooks
|
903 |
|
|
|a SEB-COLL
|
945 |
|
|
|f - -
|g 1
|h 0
|j - -
|k - -
|l he
|o -
|p $0.00
|q -
|r -
|s b
|t 38
|u 0
|v 0
|w 0
|x 0
|y .i2148076x
|z 02-26-20
|
999 |
f |
f |
|i fe59967a-5b59-5acf-96e3-018ca8cd6ab7
|s a554ec5c-5b83-5c01-9a7c-8a85946908a1
|t 0
|
952 |
f |
f |
|p Online
|a College of the Holy Cross
|b Main Campus
|c E-Resources
|d Online
|t 0
|e E-Book
|h Library of Congress classification
|i Elec File
|